Ameritas Advisory Services’s Oragenics OGEN Stock Holding History

Ameritas Advisory Services’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,000	Closed	-$1.12K	–	2077
2026 Q1	$1.12K	Buy	+2,000	New	+$1.58K	﹤0.01%	1022

Other funds holding OGEN

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

SJIM

St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Ameritas Advisory Services's OGEN Position: Q2 2026 in Review

Ameritas Advisory Services sold out of Oragenics (OGEN) in Q2 2026, closing a stake of 2,000 shares — an estimated $1.12K sold.

Ameritas Advisory Services first reported a position in OGEN in Q1 2026 and held it in 1 quarter. The position peaked at $1.12K in Q1 2026. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

Ameritas Advisory Services reported no remaining Oragenics position as of Q2 2026 after selling out during the quarter.
Ameritas Advisory Services sold 2,000 Oragenics shares in Q2 2026, an estimated $1.12K.
Ameritas Advisory Services first reported a position in Oragenics in Q1 2026 and held it in 1 quarter.
Ameritas Advisory Services's Oragenics position peaked at $1.12K in Q1 2026.
17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.